Monitoring the SessionHB 967
Died in committee
THE TEXT
“The commission shall conduct a study evaluating the prevalence of the use of psychoactive or psychotropic medication by persons who are reported to have committed suicide.”
Bill text, introduced version (I)
The bill's only operative act is a study and a report. Any policy change would have to wait for later legislation. The caption honestly says this is a study.
Study, task force, commission, reportInitial review · graded Oct 20, 2026 · Headline, summary and grade are analysis of the bill text, not a finding about any person · How we grade
relating to a study on the prevalence of the use of psychoactive or psychotropic medication by persons who have committed suicide.
Caption from analyzed text · version I.
Just a study and report. Counties of 450,000 or more, 2016 through 2022.
The bill orders the Health and Human Services Commission to study how often Texans reported to have died by suicide were taking, or had recently stopped taking, psychoactive or psychotropic medication, and whether they showed withdrawal symptoms. The study uses autopsy, toxicology, police and related records from 2016 through 2022, only for people who lived in counties with 450,000 or more residents. The commission must send a public written report to the governor, lieutenant governor and speaker by October 1, 2025, and nothing else changes in law.
Labels: ZOMBIE BILL. Died 2 times: 88R HB 551 (Died in committee) and this bill (Died in committee). Checked against 88R only.BACK FROM THE DEAD. Same text as a bill filed before that died: 88R HB 551 (Died in committee). Filed in 2 sessions, counting this one. Checked against 88R only.TRY NO. 2. Filed in 2 sessions: 88R and 89R. Checked against 88R only.NEVER GOT A HEARING. Filed Nov 12, 2024 and referred to the House Public Health committee. No public hearing. The bill died.
89R-HB967 · 2024-11-12
relating to a study on the prevalence of the use of psychoactive or psychotropic medication by persons who have committed suicide.
Just a study and report. Counties of 450,000 or more, 2016 through 2022.
The bill orders the Health and Human Services Commission to study how often Texans reported to have died by suicide were taking, or had recently stopped taking, psychoactive or psychotropic medication, and whether they showed withdrawal symptoms. The study uses autopsy, toxicology, police and related records from 2016 through 2022, only for people who lived in counties with 450,000 or more residents. The commission must send a public written report to the governor, lieutenant governor and speaker by October 1, 2025, and nothing else changes in law.
[x] STUDY, TASK FORCE, COMMISSION, REPORTanalysis confidence 90%
THE TEXT
“The commission shall conduct a study evaluating the prevalence of the use of psychoactive or psychotropic medication by persons who are reported to have committed suicide.”
Bill text, introduced version (I)
The bill's only operative act is a study and a report. Any policy change would have to wait for later legislation. The caption honestly says this is a study.
No fiscal note in the loaded record.
No verified beat found.
THANK YOU FOR CHECKING THE RECEIPT
CAMPAIGN PAID FOR BY
Not tied to this bill.
The author's campaign account only. Own money and internal transfers are separate on the member page.
Derived itemized flow · Jul 1, 2024 to Mar 25, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
$32,500.00
Also funds 124 other sitting lawmakers.
Derived recipient stock · Jul 10, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamDerived itemized flow · Jul 10, 2024 to Jun 27, 2025. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101005773, 101012329.
Missing data does not establish zero giving. Display amounts are rounded.
$32,500.00
Also funds 124 other sitting lawmakers.
Derived recipient stock · Jul 10, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamDerived itemized flow · Jul 10, 2024 to Jun 27, 2025. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101005773, 101012329.
No floor vote loaded for this bill.
No fiscal note in the loaded record.
Analysis of text version I by claude-opus-5-5, Oct 20, 2026, against the published rubric.
Filed 2 times: 88R and 89R. Checked against 88R only.
by Rep. Toth, same lead author · Died in committee · same text
Introduced textLast action, Feb 23, 2023: Referred to Public Health
Relating to a study on the prevalence of the use of psychoactive or psychotropic medication by persons who have committed suicide.
Caption, 88R bill history
Texas House · Filed Nov 12, 2024
03/06/2025 H Referred to Public Health: Mar 6 2025 11:42AM
Texas Legislature Online · Introduced
Data snapshot Oct 26, 2026 at 4:19 AM CDT. Grades, charges, quotes and corrections follow the published record.
House committee · Public Health · Final status: Died in committee
Health--Other Diseases & Medical Conditions
MEDICINE & PRESCRIPTION DRUGS
SUICIDE
HEALTH & HUMAN SERVICES COMMISSION
The text as introduced · 366 words
By: Toth H.B. No. 967 A BILL TO BE ENTITLED AN ACT relating to a study on the prevalence of the use of psychoactive or psychotropic medication by persons who have committed suicide. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. (a) In this Act: (1) "Commission" means the Health and Human Services Commission. (2) "Psychoactive medication" has the meaning assigned by Section 242.505, Health and Safety Code. (3) "Psychotropic medication" has the meaning assigned by Section 266.001, Family Code. (b) The commission shall conduct a study evaluating the prevalence of the use of psychoactive or psychotropic medication by persons who are reported to have committed suicide. The study must evaluate: (1) for persons for whom a report described by Subsection (c) indicated the use of psychoactive or psychotropic medication: (A) the period of time the person was taking psychoactive or psychotropic medication; (B) the medication the person was taking; (C) whether there is evidence of the person experiencing withdrawal symptoms; and (D) if applicable, the period of time the person was experiencing withdrawal symptoms; and (2) for persons for whom a report described by Subsection (c) did not indicate the use of psychoactive or psychotropic medication: (A) whether there is evidence of the person having recently discontinued using psychoactive or psychotropic medication; and (B) whether there is evidence of the person experiencing withdrawal symptoms. (c) In conducting the study, the commission shall use autopsy reports, toxicology reports, police reports, and other information related to persons who are reported to have committed suicide that are: (1) collected between January 1, 2016, to December 31, 2022; and (2) concerning persons who resided in counties with a population of 450,000 or more. (d) Not later than October 1, 2025, the commission shall prepare and submit to the governor, the lieutenant governor, and the speaker of the house of representatives a written report containing the results of the study. (e) The study required by this Act is a public record under Chapter 552, Government Code. (f) The commission shall comply with all applicable state and federal laws regarding personally identifiable information in conducting the study. SECTION 2. This Act takes effect September 1, 2025.